T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof

Details for Australian Patent Application No. 2006239505 (hide)

Owner immatics biotechnologies GmbH

Inventors Zeis, Matthias

Agent Pizzeys

Pub. Number AU-B-2006239505

PCT Pub. Number WO2006/114307

Priority 05009095.0 26.04.05 EP

Filing date 26 April 2006

Wipo publication date 2 November 2006

Acceptance publication date 10 May 2012

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

6 December 2007 PCT application entered the National Phase

  PCT publication WO2006/114307 Priority application(s): WO2006/114307

28 April 2011 Alteration of Name

  The name of the applicant has been altered to immatics biotechnologies GmbH

10 May 2012 Application Accepted

  Published as AU-B-2006239505

6 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006239506-Carrier for targeting nerve cells

2006239493-Phase control